Oral antimitotic agent for dogs with newly diagnosed lymphoma
Eligibility:
* Measurable disease defined by examination, radiographs, ultra-sound, CT or MRI scan
* Cytologically diagnosed Non-Hodgkins Lymphoma (histology collected at study entry)
* Any clinical stage but must have nodal involvement
* No previous targeted therapy (including prednisone)
Trial Design:
Diagnostic and staging tests may be performed at any veterinary hospital within 10 days of initiation of study. Patients will be treated at Friendship Hospital for Animals. Lymph node biopsies will be required at entry and 7 and 21 days later.
Trial Support:
Study patients receive the oral anti-mitotic agent at no charge. Laboratory, biopsy and professional fees required for the study will be provided by the sponsor from time of enrollment.









Pet owners seeking novel treatment options for animals with serious health conditions find an Animal Clinical Investigation network veterinarian participating in a clinical trial.
Animal Clinical Investigation network veterinarian and pet owner work together to determine whether the pet is eligible for the trial. Eligible pets begin treatment at an ACI network hospital.
Information from the trial is used to help develop new drugs and treatments, providing a source of hope for people whose pets face serious illnesses.